Drug Trial Radar · NCT02278367
Clinical Evaluation of Flortaucipir F 18
Last checked: Nov 20, 2026Latest source record: Sep 10, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
179
Actual
Start
Dec 2014
Primary completion
Jun 26, 2019
Study completion Jun 26, 2019
Sponsor
- Lead sponsor
- Avid RadiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Oct 30, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is designed to expand the database of flortaucipir F 18 safety and tau binding as measured by PET imaging and to provide standardized conditions for flortaucipir PET use, data collection and analysis to facilitate companion studies including, but not limited to, longitudinal studies of aging, depression, and traumatic brain injury.
Conditions
- Alzheimer's Disease
- Traumatic Brain Injury
- Depression
Interventions
Flortaucipir F18Drug
IV injection, 370 MBq (10 mCi), up to two doses
Brain PET scanProcedure
positron emission tomography (PET) scan of the brain
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events Related to Flortaucipir AdministrationTime frame: within 48 hours of drug administration
- Flortaucipir PET Scan SUVrTime frame: baseline and follow-up scans
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Banner Alzheimer's Institute
Phoenix, Arizona
Yale University
New Haven, Connecticut
Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, Nevada
University of Pennsylvania
Philadelphia, Pennsylvania
Center for Vital Longevity at the University of Texas at Dallas
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.